改良乳腺二维剪切波弹性成像算法消除假阴性病例
这项前瞻性单中心研究纳入298例患者394个乳腺病灶,比较标准算法与新型二维剪切波弹性成像算法。新算法将敏感度从0.45提升至1.00,特异度从0.94降至0.81,AUC从0.87升至0.95,阴性预测值为1.00,几乎消除了「软癌」伪像。
要点
- 新算法最大硬度值:良性病灶3.51 m/s,恶性病灶8.45 m/s。
- 阈值5.0 m/s时新算法敏感度1.00、特异度0.81、阴性预测值1.00。
- 新算法可对所有BI-RADS 4类病灶进行降级。
核心结论
- 使用新型乳腺剪切波弹性成像算法显著提高敏感度,特异度小幅下降,几乎消除了「软癌」伪像。
研究设计与样本
- 前瞻性单中心研究,经当地机构审查委员会批准并符合《健康保险流通与责任法案》,2019年4月25日至2022年5月2日期间在Siemens Sequoia超声设备上采集乳腺超声原始剪切波数据,最终纳入298例患者394个病灶(201个良性经>2年随访证实,193个经活检:65个良性、128个恶性),以活检病理或>2年随访为参考标准。
诊断标准与关键数值
- 新算法阈值5.0 m/s时,敏感度从标准算法的0.45升至1.00,特异度从0.94降至0.81,阳性预测值0.72,阴性预测值1.00,阴性似然比0.00;AUC标准算法0.87、新算法0.95。
临床应用与阅片要点
- 新算法显著提高乳腺病灶良恶性鉴别的敏感度和阴性预测值,并允许对所有BI-RADS 4类病灶进行降级。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Two-dimensional shear wave elastography (SWE) has been limited in breast lesion characterization due to false-negative results from artifacts. The aim of this study was to evaluate an updated Food and Drug Administration-approved breast 2D-SWE algorithm and compare with the standard algorithm (SA).
MATERIALS AND METHODS: This prospective, single-center study was approved by our local institutional review board and Health Insurance Portability and Accountability Act compliant. From April 25, 2019 to May 2, 2022, raw shear wave data were saved on patients having screening or diagnostic breast ultrasound on a Siemens Sequoia US. After removing duplicate images and those without biopsy diagnosis or stability over 2 years, there were 298 patients with 394 lesions with biopsy-proven pathology or >2-year follow-up. Raw data were processed using the SA and a new algorithm (NA). Five-millimeter regions of interest were placed in the highest stiffness in the lesion or adjacent 3 mm on the SA. Stiffness values (shear wave speed, max) in this location from both algorithms were recorded. Statistics were calculated for comparing the 2 algorithms.
RESULTS: The mean patient age was 56.3 ± 16.1 years (range, 21-93 years). The mean benign lesion size was 10.7 ± 8.0 mm (range, 2-46 mm), whereas the mean malignant lesion size was 14.9 ± 7.8 mm (range, 4-36 mm). There were 201 benign (>2-year follow-up) and 193 biopsied lesions (65 benign; 128 malignant). The mean maximum stiffness for benign lesions was 2.37 m/s (SD 1.26 m/s) for SA and 3.51 m/s (SD 2.05 m/s) for NA. For malignant lesions, the mean maximum stiffness was 4.73 m/s (SD, 1.71 m/s) for SA and 8.45 m/s (SD, 1.42 m/s) for NA. The area under the receiver operating characteristic curve was 0.87 SA and 0.95 NA when using the optimal cutoff value. Using a threshold value of 5.0 m/s for NA and comparing to SA, the sensitivity increased from 0.45 to 1.00 and the specificity decreased from 0.94 to 0.81; the positive predictive value was 0.72, the negative predictive value was 1.00, and the negative likelihood ratio was 0.00.
CONCLUSIONS: Using a new breast SWE algorithm significantly improves the sensitivity of the technique with a small decrease in specificity, virtually eliminating the "soft" cancer artifact. The new 2D-SWE algorithm significantly increases the sensitivity and negative predictive value in characterizing breast lesions as benign or malignant and allows for downgrading all BI-RADS 4 lesions.
引用
- Barr RG, Engel A, Kim S, et al. Improved Breast 2D SWE Algorithm to Eliminate False-Negative Cases. Invest Radiol. 2023. PMID: 36939607. doi:10.1097/RLI.0000000000000972
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。